Forty Seven Inc(NASDAQ:FTSV) stock News

FTSV Latest News, Press Relases and Analysis

All

Press Releases

5 years ago - By: Bloomberg - Mentions: GILD SAGE AMGN CYTK ...

Gilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for Growth

5 years ago - By: Bloomberg - Mentions: TRIL.CA PFE GILD

Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge

5 years ago - By: Bloomberg - Mentions: ALLO ATRA GILD JUNO ...

Orca Bio Emerges as $1 Billion-Plus Biotech With Mystery Backer

6 years ago - By: The Motley Fool - Mentions: GILD

Why Forty Seven Stock Skyrocketed 64.5% in March

6 years ago - By: Benzinga - Mentions: GILD

Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19

6 years ago - By: Seeking Alpha - Mentions: GILD

Gilead completes Forty Seven buy (NASDAQ:GILD)

6 years ago - By: Seeking Alpha - Mentions: GILD

Gilead competes Forty Seven buy (NASDAQ:GILD)

6 years ago - By: Benzinga - Mentions: AIM MOR XBI ANGO ...

The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation

6 years ago - By: InvestorPlace - Mentions: GILD

Gilead Sciences Pins Its Hopes on Remdesivir

6 years ago - By: StockNews.com - Mentions: IMMU W PVH VIR ...

Best & Worst Performing Mid Cap Stocks for April 6, 2020

6 years ago - By: The Motley Fool - Mentions: GILD

Should You Buy Forty Seven Before Gilead Sciences' Acquisition Closes?

6 years ago - By: InvestorPlace - Mentions: GILD SPY GPS F ...

Gilead Sciences’ Coronavirus Treatment Has Big-Time Potential

6 years ago - By: Zacks Investment Research - Mentions: GO TRIL

Demand for Essential Goods Rises Amid Coronavirus: 3 Winners

6 years ago - By: InvestorPlace - Mentions: GILD

GILD Stock Remains a Smart Play Now and in the Future

6 years ago - By: InvestorPlace - Mentions: GILD

Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap

6 years ago - By: Zacks Investment Research - Mentions: VIRT NOVN MRNA

Top Ranked Momentum Stocks to Buy for March 30th

6 years ago - By: Seeking Alpha - Mentions: GILD

Gilead nearing finish line on Forty Seven buy

6 years ago - By: InvestorPlace - Mentions: MRNA GILD LAKE APT ...

Stop Chasing Coronavirus Plays Like Moderna Stock

6 years ago - By: Halper Sadeh LLP - Mentions: GCAP MINI

SHAREHOLDER INVESTIGATION: Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - GCAP, FTSV, MINI

6 years ago - By: Zacks Investment Research - Mentions: AYTU VIR CODX CNTG

Coronavirus Scare Supports These Biotech ETFs & Stocks

6 years ago - By: Seeking Alpha

Forty Seven EPS beats by $0.10

6 years ago - By: InvestorPlace - Mentions: GILD

Remdesivir, Other Positive Catalysts Should Lift Gilead Stock

6 years ago - By: Halper Sadeh LLP - Mentions: ETFC MEET

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - ETFC, FTSV, MEET

6 years ago - By: Halper Sadeh LLP - Mentions: MINI FSB

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - FTSV, MINI, FSB

6 years ago - By: Bragar Eagel & Squire, P.C.

FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm

6 years ago - By: StockNews.com - Mentions: BNTX GFI AU NG ...

Best & Worst Performing Mid Cap Stocks for March 16, 2020

6 years ago - By: Zacks Investment Research - Mentions: REGN AZN GILD LLY

Forty Seven Inc (FTSV) Stock News

FTSV Latest News, Press Relases and Analysis

Gilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for Growth

Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge

Orca Bio Emerges as $1 Billion-Plus Biotech With Mystery Backer

Why Forty Seven Stock Skyrocketed 64.5% in March

Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19

Gilead completes Forty Seven buy (NASDAQ:GILD)

Gilead competes Forty Seven buy (NASDAQ:GILD)

The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation

Gilead Sciences Pins Its Hopes on Remdesivir

Best & Worst Performing Mid Cap Stocks for April 6, 2020

Should You Buy Forty Seven Before Gilead Sciences' Acquisition Closes?

Gilead Sciences’ Coronavirus Treatment Has Big-Time Potential

Demand for Essential Goods Rises Amid Coronavirus: 3 Winners

GILD Stock Remains a Smart Play Now and in the Future

Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap

Top Ranked Momentum Stocks to Buy for March 30th

Gilead nearing finish line on Forty Seven buy

Stop Chasing Coronavirus Plays Like Moderna Stock

SHAREHOLDER INVESTIGATION: Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - GCAP, FTSV, MINI

Coronavirus Scare Supports These Biotech ETFs & Stocks

Forty Seven EPS beats by $0.10

Remdesivir, Other Positive Catalysts Should Lift Gilead Stock

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - ETFC, FTSV, MEET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - FTSV, MINI, FSB

FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm

Best & Worst Performing Mid Cap Stocks for March 16, 2020

4 Big Drug/Biotech Stocks Up in Coronavirus-Hit Economy